Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
British Journal of Haematology
|
September 21, 2006
High dose calcitriol may reduce thrombosis in cancer patients
Tomasz M Beer, Peter M Venner, Christopher W Ryan, et al.
Cancer
|
October 27, 2007
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel
Tomasz M Beer, Christopher W Ryan, Peter M Venner, et al.
Cancer
|
March 19, 2008
Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas
Christopher W Ryan, Anthony G Montag, Janet R Hosenpud, et al.
Sarcoma
|
June 15, 2013
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
Ken Kikuchi, George R Wettach, Christopher W Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2004
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies
Christopher W Ryan, Nicholas J Vogelzang, Everett E Vokes, et al.
Investigational New Drugs
|
April 28, 2012
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma
Christopher W Ryan, Chacon Matias, Mark Agulnik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group
Christopher W Ryan, Bryan H Goldman, Primo N Lara, et al.
Cancer
|
April 23, 2008
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial
Tomasz M Beer, Alshad S Lalani, Stella Lee, et al.
Journal for Immunotherapy of Cancer
|
July 27, 2024
Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort
Sandip P Patel, Megan Othus, Young Kwang Chae, et al.
Annals of Surgical Oncology
|
February 2, 2018
Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas
Eric Lu, Kelly S Perlewitz, James B Hayden, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
British Journal of Haematology
|
September 21, 2006
High dose calcitriol may reduce thrombosis in cancer patients
Tomasz M Beer, Peter M Venner, Christopher W Ryan, et al.
Cancer
|
October 27, 2007
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel
Tomasz M Beer, Christopher W Ryan, Peter M Venner, et al.
Cancer
|
March 19, 2008
Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas
Christopher W Ryan, Anthony G Montag, Janet R Hosenpud, et al.
Sarcoma
|
June 15, 2013
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
Ken Kikuchi, George R Wettach, Christopher W Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2004
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies
Christopher W Ryan, Nicholas J Vogelzang, Everett E Vokes, et al.
Investigational New Drugs
|
April 28, 2012
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma
Christopher W Ryan, Chacon Matias, Mark Agulnik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group
Christopher W Ryan, Bryan H Goldman, Primo N Lara, et al.
Cancer
|
April 23, 2008
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial
Tomasz M Beer, Alshad S Lalani, Stella Lee, et al.
Journal for Immunotherapy of Cancer
|
July 27, 2024
Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort
Sandip P Patel, Megan Othus, Young Kwang Chae, et al.
Annals of Surgical Oncology
|
February 2, 2018
Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas
Eric Lu, Kelly S Perlewitz, James B Hayden, et al.
Page
of 12